How well did the educational sessions give a balanced view of therapeutic options, including the use of generic names?
If you rated any of the above questions with 'fair,' 'poor,' 'disagree,' or 'strongly disagree' please explain:
Explain the new ESA restrictions and their effect on clinical practice, especially the use of blood transfusions
Describe the role of IV Iron in decreasing the use of blood transfusion
Compare the available IV Iron products in order to guide practitioners in making the most appropriate choices for their patients
What questions have arisen in your practice for which you need answers/strategies that you can implement?
What patient problems or patient challenges do you feel you are not able to address appropriately or to your satisfaction?
What problems are your patients communicating to you that need attention or follow-up?